Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedical Engineering Letters is Scopus-indexed (Q2, CiteScore 5.9), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer Verlag.
Checked against the index lists dated .
ISSN 2093-985XVerify ISSN ↗2093-9868Verify ISSN ↗
Publisher: Springer Verlag
Cost to publish: About US$3,890 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biomedical Engineering | 130 / 342 | 62nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present, best quartile Q2, CiteScore 5.9.
Biomedical Engineering Letters is Q2 in Biomedical Engineering (rank 130 of 342), by CiteScore 2025.
Biomedical Engineering Letters is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.9, which places it in quartile Q2 at the 62nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.695, quartile Q2, with an H-index of 52.
The publisher lists an article processing charge of about US$3,890 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Biomedical Engineering Letters is published by Springer Verlag. Its print ISSN is 2093-985X and its online ISSN is 2093-9868.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomedical Engineering Letters has an h-index of 60 and a 2-year mean of 4.28 citations per paper (OpenAlex). Its Scopus CiteScore is 5.9, quartile Q2. On 2-year citations it ranks #95 of 322 Scopus journals in Biomedical Engineering.
Biomedical Engineering Letters published 88 papers in 2025; its busiest recent year was 2024 with 108. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from South Korea (56.7%), China (11.7%) and United States (7.8%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.